|
Volumn 164, Issue 8 II, 2001, Pages
|
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
|
Author keywords
Allergic rhinitis; Anti IgE; Asthma; IgE; Monoclonal antibody
|
Indexed keywords
ALLERGEN;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
IMMUNOGLOBULIN E;
IMMUNOGLOBULIN E ANTIBODY;
IMMUNOGLOBULIN E RECEPTOR;
OMALIZUMAB;
UNCLASSIFIED DRUG;
ASTHMA;
B LYMPHOCYTE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EFFECTOR CELL;
HUMAN;
HUMAN CELL;
IMMUNOGLOBULIN PRODUCTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RASH;
RECEPTOR BINDING;
RESPIRATORY TRACT ALLERGY;
REVIEW;
SYMPTOM;
|
EID: 0035888750
PISSN: 1073449X
EISSN: None
Source Type: Journal
DOI: 10.1164/ajrccm.164.supplement_1.2103025 Document Type: Review |
Times cited : (135)
|
References (32)
|